News



 
 

Welcome  To  AIT

Applied Immune Technologies (AIT) is a drug development company specializing in T-Cell Receptor-Like (TCRL) antibodies that are targeted to intracellular-derived peptides for a variety of therapeutic and diagnostic applications. AIT is also focused on identification and validation of novel therapeutic targets.


Our vision is to develop highly specific 3rd generation antibodies that will revolutionize the fields of cancer, viral, and autoimmune diseases, as well as other targeted immunotherapies.

 

 






 


 


Applied Immune Technologies Ltd © All Rights Reserved

 
ארטוויז'ן | Quickyweb